Latest multi-asset & multi-strategy thinking
-
What does the data say? Where have the safe havens gone?
27 May 2022
In this month’s instalment of our visual series on topical themes, we look at how various asset classes are holding up in a turbulent year for financial markets.
-
Is stagflation set to make an unwanted return?
18 May 2022
Surging inflation is leading to fears the world economy could be heading towards recession. While there are diverging views on whether we are entering a new era of stagflation, the medium-term growth-inflation trade off looks set to worsen with big implication for asset prices, argue Michael Grady and Peter Fitzgerald.
-
What does the data say? Ukraine-Russia: The human and economic costs of war
29 Apr 2022
In this month’s instalment of our visual series on topical themes, we look at the far-reaching human and economic consequences of the Ukraine-Russian war.
-
A new Cold War? What the Russia-Ukraine crisis means for globalisation and markets
28 Apr 2022
The world has become more volatile and unpredictable with Russia’s invasion of Ukraine. But while Vladimir Putin may have dealt globalisation another blow, China and the West will want to prevent the world splitting into two competing blocs.
-
Multi-asset allocation views: Five lessons for investors during turbulent times
22 Apr 2022
From Russia’s invasion of Ukraine to surging inflation, risk has well and truly returned to markets in 2022. Sunil Krishnan offers useful insights for investors unaccustomed to such challenging times.
-
Economic volatility: The end of the Great Moderation?
6 Apr 2022
Russia’s invasion of Ukraine, following hot on the heels of the pandemic, could hasten the transition to a new, more volatile economic environment. That would have major ramifications for financial markets and investors, argues Michael Grady.
-
China, inflation and politics: Three reasons for EM turbulence
24 Feb 2022
Emerging market assets have underperformed developed market peers over the past decade. While this has led to valuation gaps, selectivity will be critical, argues David Nowakowski.
-
The future of pharma: Increased returns or the age of biotech?
8 Dec 2021
After decades of low returns on research and development (R&D), the healthcare sector is producing a slew of innovations, from drugs to diagnostics. But with many coming from new entrants, will big pharmaceutical companies manage to keep up with the times?
-
Multi-asset allocation views: How durable is ‘transitory’ inflation?
22 Nov 2021
As central banks continue to stretch what ‘transitory’ inflation means, Sunil Krishnan explores how price pressures are changing and the implications for multi-asset portfolios.
-
The long decline: Why trend economic growth is set to go on falling
12 Nov 2021
Trend rates of economic growth, which have been on the decline for decades in the world’s leading economies, look set to fall further. That will have big implications for governments, companies, households and investors, argues Stewart Robertson.
-
Multi-asset allocation views: Emerging themes for portfolio diversification
22 Sep 2021
Diversification is a core tenet of multi-asset investing. Sunil Krishnan explores thematic ideas that may help diversify portfolios in the current market environment.
-
Multi-asset allocation views: Moving short on duration
16 Jul 2021
A strong economic recovery and continued reflationary bias from the Federal Reserve could push long-dated yields higher on US Treasuries, says Sunil Krishnan.
Subscribe to AIQ
Receive our award-winning insight on key investment themes, direct to your inbox.
Important information
This site is intended for U.S. Institutional Investors only. If you are not a U.S. Institutional Investor, please visit the global Aviva Investors homepage.
The content on this site and any posts on Aviva’s other social media or third party platforms is provided for informational and educational purposes (“Online Content”) only, and nothing herein constitutes investment, legal, accounting or tax advice. The Online Content is general in nature, not directed to any category of investors and should not be regarded as individualized, a recommendation, investment advice or a suggestion to engage in or refrain from any investment-related course of action. Investment decisions and the appropriateness of this material should be made based on an investor's individual objectives and circumstances and in consultation with their advisors. Views expressed in “posts” (including podcasts, videos, blogs and social media) by Aviva’s personnel are not necessarily the views of Aviva or its respective affiliates.
Information, examples and any charts shown in the Online Content are for information purposes only current as of the date of this material and is subject to change without notice. Information is obtained from third party sources deemed reliable, but there is no representation or warranty as to its accuracy, completeness or reliability. In addition, posts may include third-party advertisements; Aviva has not reviewed such advertisements and does not endorse any advertising content contained therein.
This material shown in the Online Content may include estimates, outlooks, projections and other “forward-looking statements.” Past performance does not predict future returns. There can be no assurances that the investment objectives will be achieved or investment strategies will be successful. Investments in fixed income entails risk. Due to a variety of factors, actual events or market behavior may differ significantly from any views expressed. Indexes are unmanaged and are not available for direct investment. Past performance is no guarantee of future results.
Aviva Investors Americas LLC is an investment adviser registered with the U.S. Securities and Exchange Commission. Registration as an investment adviser does not imply any special skill or training. Aviva products and services may not be available in all jurisdictions or to all client types.
Except as otherwise authorized, this information may not be shown, copied, transmitted, or otherwise given to any third party without Aviva's prior written consent.